EEM News and Press, iShares MSCI Emerging Index Fund From 01/09/23

Summary Recession foretold in developed markets (DM), a pause in central bank rate hikes and China’s reopening help shape 2023 and reinforce our tactical views. European equities led DM stocks higher. Surprisingly weak U.S. services data spurred bets for Federal Reserve rate cuts...

Summary Emerging markets are likely to do well in the coming decade due to reasonably low valuations. Emerging markets have declined for decades versus the S&P 500, but that could be reversing. However, EDC, which is a leveraged ETF, should be handled with care. ...

Summary Global business activity fell for a fifth consecutive month in December, with the rate of decline moderating slightly amid improved supply conditions but still rounding off the worst quarter since 2009 barring lockdown months. At 48.2 in December, the Global PMI - compiled by S&...

Summary We expect COVID-19 to continue its transition to a global endemic and the status quo to prevail in Russia's war in Ukraine, with no material implications for the global economy. Mild recessions are forecast in the United States and Europe, but resilience in Asia Pacific will pre...

Summary After a 16% rally since the bottom on October 25, the Vanguard FTSE Emerging Markets ETF (VWO) appears poised for further upside, with the China rally leading the way. While valuations have increased over recent months, the VWO remains undervalued from a historical perspective. ...

Summary Global equities closed out their worst year since the 2008 financial crisis as central banks launched increasingly aggressive efforts to bring rampant inflation under control. Much of the US’s underperformance versus its peers is an outgrowth of its much larger exposure t...

Summary We expect 2023 to be a year of transition, with gradual fading of price pressures allowing policymakers and market participants to take a more balanced approach to assessing growth and inflation dynamics. The near-term outlook calls for more of the same: high inflation and rate ...

Summary For 40 years, steadily declining inflation and interest rates buoyed equity returns. That changed abruptly last year. Investors must now adjust expectations to a new macroeconomic and market landscape that will require a fresh mindset to reach long-term goals. By...

Summary 2022 was the first year since 2016 that value investing thoroughly trounced growth investing. Growth had a nice spurt off the lows in June and October ’22 but the higher 10-year Treasury yield is acting like a wet blanket for growth stocks. I continue to think that no...

Summary A table with the drifts of SDS and 21 other leveraged ETFs. Biotechnology leveraged ETFs have the worst monthly decay. The annual decay of SDS is close to zero on average, but it may be harmful for long periods of time. The ProShares UltraShort S&P 500 ETF ( ...